Zylö Receives $294,000 NIH Phase I Grant to Advance its Cutaneous Lupus Program
31 mai 2023 13h00 HE
|
Zylö Therapeutics
Funds to be used to demonstrate efficacy in a new mouse model of cutaneous lupus GREENVILLE, SC, May 31, 2023 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the Z-pod® topical delivery...